and its partner, BioNTech, have officially submitted data to the U.S. Food and Drug Administration () to have its vaccine authorized for use in children aged six months to four years old.The company announced the move on Tuesday afternoon, following reports earlier in the day that the regulatory agency was urging them to submit an application soon. Despite the push from regulators to expand eligibility for the shots to include young children, the move would be controversial and would also make the U.S. the only nation in America to jab children under one years old for Covid.
Load More
Load More